KEQU Stock Overview
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Kewaunee Scientific Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$32.84 |
| 52 Week High | US$55.62 |
| 52 Week Low | US$16.51 |
| Beta | 0.73 |
| 11 Month Change | -11.08% |
| 3 Month Change | -36.81% |
| 1 Year Change | 83.46% |
| 33 Year Change | 148.79% |
| 5 Year Change | 110.18% |
| Change since IPO | 115.34% |
Recent News & Updates
The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out
Sep 24Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Sep 17
With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case
Sep 10Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price
Aug 23Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance
Jul 11Recent updates
The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out
Sep 24Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Sep 17With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case
Sep 10Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price
Aug 23Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance
Jul 11Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet
Jun 19Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely
Dec 18Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital
Jul 02Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet
Mar 10Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M
Sep 08Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M
Jun 30Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?
Apr 12Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt
Dec 28
Kewaunee Scientific reports Q2 results
Dec 09Shareholder Returns
| KEQU | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.3% | 1.1% | 1.5% |
| 1Y | 83.5% | 28.6% | 33.1% |
Return vs Industry: KEQU exceeded the US Medical Equipment industry which returned 28.6% over the past year.
Return vs Market: KEQU exceeded the US Market which returned 33.1% over the past year.
Price Volatility
| KEQU volatility | |
|---|---|
| KEQU Average Weekly Movement | 8.9% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: KEQU has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: KEQU's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 1,006 | Thomas Hull | www.kewaunee.com |
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Kewaunee Scientific Corporation Fundamentals Summary
| KEQU fundamental statistics | |
|---|---|
| Market cap | US$94.77m |
| Earnings (TTM) | US$18.47m |
| Revenue (TTM) | US$202.31m |
5.1x
P/E Ratio0.5x
P/S RatioIs KEQU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KEQU income statement (TTM) | |
|---|---|
| Revenue | US$202.31m |
| Cost of Revenue | US$149.68m |
| Gross Profit | US$52.63m |
| Other Expenses | US$34.15m |
| Earnings | US$18.47m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.43 |
| Gross Margin | 26.01% |
| Net Profit Margin | 9.13% |
| Debt/Equity Ratio | 54.9% |
How did KEQU perform over the long term?
See historical performance and comparison